MFIM
IMGN

Mesirow Financial Investment Management’s Immunogen Inc IMGN Stock Holding History

Mesirow Financial Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,094
Closed -$271K – 573
2023
Q3 		$271K Buy
+17,094
New +$284K 1.18% 42

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Mesirow Financial Investment Management's IMGN Position: Q4 2023 in Review

Mesirow Financial Investment Management sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 17,094 shares — an estimated $271K sold.

Mesirow Financial Investment Management first reported a position in IMGN in Q3 2023 and held it in 1 quarter. The position peaked at $271K in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Mesirow Financial Investment Management reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 17,094 Immunogen Inc shares in Q4 2023, an estimated $271K.
  • Mesirow Financial Investment Management first reported a position in Immunogen Inc in Q3 2023 and held it in 1 quarter.
  • Mesirow Financial Investment Management's Immunogen Inc position peaked at $271K in Q3 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2023, filed 10 Jan 2024.